Here's Why Demand for Ozempic and Wegovy Could Soar Even Higher

Novo Nordisk's stock may not look all that expensive when you're focusing on the long-term potential.Odds are that if you hear the word "Ozempic," you likely associate that with weight loss. It's hard not to given all the posts on social media about users losing weight thanks to the drug. But many people may be surprised that it's not actually approved as a weight loss treatment -- regulators have approved it for diabetes. People have simply been taking it off-label because of its ability to help them lose ...